ArticleThe Journal of clinical investigation2022

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation.

Jingjing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.